Glioblastoma: Despite All the Disappointment, There Has Been Progress
- Interview by Lauren Zoeller
- Written by
-
Roger
Stupp
MD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
-
Stupp R, Hegi ME, Gorlia T, et al. Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation: Final results of the multicenter, randomized, open-label, controlled, phase III CENTRIC study. ASCO Meeting Abstracts. June 17, 2013 2013;31(15_suppl):LBA2009.
-
Stupp R, Wong ET, Kanner AA, et al. NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality. Eur J Cancer. Sep 2012;48(14):2192-2202.
-
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM). In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000- [cited 2013 Oct 20]. Available from: http://clinicaltrials.gov/ct2/show/NCT00916409. NLM Identifier:NCT00916409.
Disclosure statements are available on the authors' profiles:
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.